Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

被引：55

作者：

Stader, Felix ^{[1
,2
,3
]}

Khoo, Saye ^{[4
]}

Stoeckle, Marcel ^{[1
,2
,3
]}

Back, David ^{[4
]}

Hirsch, Hans H. ^{[1
,2
,5
]}

Battegay, Manuel ^{[1
,2
,3
]}

Marzolini, Catia ^{[1
,2
,3
,4
]}

机构：

[1] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Med, Basel, Switzerland

[2] Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Dept Clin Res, Basel, Switzerland

[3] Univ Basel, Basel, Switzerland

[4] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England

[5] Univ Basel, Dept Biomed, Transplantat & Clin Virol, Basel, Switzerland

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2020年 / 75卷 / 10期

关键词：

ENZYMES; CYP1A2; CYP3A4;

D O I：

10.1093/jac/dkaa253

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：3084 / 3086

页数：3

共 10 条

[1]

Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]

[2] Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture [J].

Dickmann, Leslie J. ;

Patel, Sonal K. ;

Rock, Dan A. ;

Wienkers, Larry C. ;

Slatter, J. Greg .

DRUG METABOLISM AND DISPOSITION, 2011, 39 (08) :1415-1422

[3] Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin [J].

Magnusson, M. O. ;

Dahl, M-L ;

Cederberg, J. ;

Karlsson, M. O. ;

Sandstrom, R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (01) :52-62

[4] Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly [J].

Stader, Felix ;

Kinvig, Hannah ;

Penny, Melissa A. ;

Battegay, Manuel ;

Siccardi, Marco ;

Marzolini, Catia .

CLINICAL PHARMACOKINETICS, 2020, 59 (03) :383-401

[5] A Comprehensive Framework for Physiologically-Based Pharmacokinetic Modeling in Matlab [J].

Stader, Felix ;

Penny, Melissa A. ;

Siccardi, Marco ;

Marzolini, Catia .

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (07) :444-459

[6] Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes [J].

Stader, Felix ;

Siccardi, Marco ;

Battegay, Manuel ;

Kinvig, Hannah ;

Penny, Melissa A. ;

Marzolini, Catia .

CLINICAL PHARMACOKINETICS, 2019, 58 (04) :483-501

[7]

Yeh RF, 2006, JAIDS-J ACQ IMM DEF, V42, P52

[8] Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnover [J].

Yeo, K. Rowland ;

Walsky, R. L. ;

Jamei, M. ;

Rostami-Hodjegan, A. ;

Tucker, G. T. .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (03) :160-173

[9] The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients [J].

Yuan, Jing ;

Zou, Rougrong ;

Zeng, Lijiao ;

Kou, Shanglong ;

Lan, Jianfeng ;

Li, Xiaohe ;

Liang, Yanhua ;

Ding, Xiaoyan ;

Tan, Guoyu ;

Tang, Shenghong ;

Liu, Lei ;

Liu, Yingxia ;

Pan, Yanchao ;

Wang, Zhaoqin .

INFLAMMATION RESEARCH, 2020, 69 (06) :599-606

[10] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J].

Zhou, Fei ;

Yu, Ting ;

Du, Ronghui ;

Fan, Guohui ;

Liu, Ying ;

Liu, Zhibo ;

Xiang, Jie ;

Wang, Yeming ;

Song, Bin ;

Gu, Xiaoying ;

Guan, Lulu ;

Wei, Yuan ;

Li, Hui ;

Wu, Xudong ;

Xu, Jiuyang ;

Tu, Shengjin ;

Zhang, Yi ;

Chen, Hua ;

Cao, Bin .

LANCET, 2020, 395 (10229) :1054-1062

← 1 →